Company · CIK 0001626878 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
XBiotech Inc. · XBIT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2019 PForm 4 → | Mar 5, 4:25 pm EST | Fondation Rennes10% Owner | 16,426 | $7.91 | $129,930 | 3,910,282 | +0.42% | plan? |
| Feb 27, 2019 PForm 4 → | Mar 4, 10:29 am EST | Fondation Rennes10% Owner | 45,574 | $8.14 | $370,835 | 3,893,856 | +1.18% | plan? late |
| Feb 7, 2019 SForm 4 → | Mar 4, 4:13 pm EST | Sushma ShivaswamyChief Scientific Officer | 4,500 | $10.00 | $45,000 | 0 | −100% | plan? late |
| Feb 7, 2019 MForm 4 → | Mar 4, 4:13 pm EST | Sushma ShivaswamyChief Scientific Officer | 4,500 | $2.50 | $11,250 | 4,500 | — | plan? late |
| Dec 24, 2018 PForm 4/A → | Mar 4, 2019, 3:40 pm EST | W Thorpe McKenzieDirector, 10% Owner | 44,838 | $5.52 | $247,369 | 47,738 | +1,546% | plan? |
| Dec 24, 2018 PForm 4 → | Dec 28, 4:17 pm EST | W Thorpe McKenzieDirector, 10% Owner | 29,802 | $5.73 | $170,799 | 32,702 | +1,028% | plan? late amended |
| Dec 21, 2018 PForm 4 → | Feb 14, 2019, 2:38 pm EST | Fondation Rennes10% Owner | 112,300 | $9.25 | $1,039,049 | 3,698,282 | +3.13% | plan? late |
| Dec 19, 2018 MForm 4 → | Dec 20, 11:00 am EST | John SimardChief Executive Officer, Director, 10% Owner | 50,000 | $2.50 | $125,000 | 6,327,060 | — | plan? |
| Nov 9, 2018 PForm 4 → | Nov 13, 4:50 pm EST | W Thorpe McKenzieDirector, 10% Owner | 2,900 | $3.74 | $10,842 | 2,900 | — | plan? |
| Oct 4, 2018 SForm 4 → | Oct 4, 4:28 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 385,000 | $3.00 | $1,155,000 | 3,398,600 | −10.2% | plan? |
| Sep 26, 2018 SForm 4 → | Oct 1, 1:18 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 17,634 | $3.05 | $53,798 | 3,783,600 | −0.46% | plan? late |
| Sep 12, 2018 SForm 4 → | Sep 18, 12:37 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 49,584 | $3.07 | $152,095 | 3,801,234 | −1.29% | plan? late |
| Sep 7, 2018 SForm 4 → | Sep 11, 5:25 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 29,603 | $3.31 | $98,097 | 3,850,818 | −0.76% | plan? |
| Sep 4, 2018 SForm 4 → | Sep 6, 4:35 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 18,179 | $3.85 | $70,056 | 3,880,421 | −0.47% | plan? |
| Aug 9, 2018 SForm 4 → | Aug 13, 5:41 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 9,809 | $3.99 | $39,147 | 0 | −100% | plan? |
| Aug 6, 2018 SForm 4 → | Aug 8, 4:38 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 15,792 | $3.97 | $62,684 | 121,309 | −11.5% | plan? |
| Aug 1, 2018 SForm 4 → | Aug 3, 4:27 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 62,524 | $3.98 | $248,868 | 25,601 | −70.9% | plan? |
| Jul 30, 2018 SForm 4 → | Aug 1, 12:53 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 11,875 | $4.45 | $52,863 | 88,125 | −11.9% | plan? |
| Mar 21, 2018 SForm 4 → | Mar 26, 3:39 pm EDT | Queena HanVP Finance & HR | 80,000 | $4.73 | $378,101 | 0 | −100% | plan? late |
| Mar 21, 2018 MForm 4 → | Mar 26, 3:39 pm EDT | Queena HanVP Finance & HR | 80,000 | $2.50 | $200,000 | 8,201 | — | plan? late |
| May 24, 2017 FMForm 4 → | May 25, 5:12 pm EDT | John SimardChief Executive Officer, Director, 10% Owner | 356,207 | $3.29 | $1,173,019 | 6,277,060 | — | plan? |
| Nov 15, 2016 SForm 4 → | Nov 17, 4:01 pm EST | Queena HanVP Finance & HR | 19,573 | $15.00 | $293,595 | 0 | −100% | plan? |
| Nov 15, 2016 MForm 4 → | Nov 17, 4:01 pm EST | Queena HanVP Finance & HR | 19,573 | $0.74 | $14,484 | 19,573 | — | plan? |
| Sep 8, 2016 SForm 4 → | Sep 12, 3:45 pm EDT | Queena HanVP Finance & HR | 427 | $15.00 | $6,405 | 0 | −100% | plan? |
| Sep 8, 2016 MForm 4 → | Sep 12, 3:45 pm EDT | Queena HanVP Finance & HR | 427 | $0.77 | $329 | 427 | — | plan? |
| May 26, 2016 PForm 4 → | May 26, 3:24 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 20,000 | $13.96 | $279,115 | 5,000 | — | plan? amended |
| May 20, 2016 PForm 4 → | May 20, 1:44 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 1,500 | $13.75 | $20,618 | 5,750 | +35.3% | plan? |
| Mar 17, 2016 OForm 4 → | Mar 22, 6:04 pm EDT | John SimardDirector, 10% Owner | 500,000 | $10.00 | $5,000,000 | 6,153,267 | — | plan? late |
| Mar 17, 2016 OForm 4 → | Mar 22, 6:02 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 500,000 | $10.00 | $5,000,000 | 3,898,600 | — | plan? late |
| Dec 18, 2015 SForm 4/A → | Dec 23, 8:38 am EST | Queena HanVP Finance / HR | 30,000 | $10.38 | $311,443 | 0 | −100% | plan? |
| Dec 18, 2015 MForm 4/A → | Dec 23, 8:38 am EST | Queena HanVP Finance / HR | 30,000 | $0.72 | $21,600 | 10,000 | — | plan? |
| Dec 18, 2015 SForm 4 → | Dec 22, 7:23 pm EST | Queena HanVP Finance / HR | 20,000 | $10.45 | $208,970 | 0 | −100% | plan? |
| Dec 18, 2015 MSForm 4 → | Dec 22, 7:23 pm EST | Queena HanVP Finance / HR | 40,000 | $3.11 | $124,343 | 0 | — | plan? |
| Nov 25, 2015 GForm 4 → | Dec 2, 11:29 am EST | W Thorpe McKenzieDirector, 10% Owner | 28,400 | — | — | 5,000 | — | plan? late |
| Nov 16, 2015 SForm 4/A → | Nov 19, 11:00 am EST | Michael StecherMedical Director | 1,800 | $14.00 | $25,200 | 0 | −100% | plan? |
| Nov 16, 2015 MForm 4/A → | Nov 19, 11:00 am EST | Michael StecherMedical Director | 1,800 | $5.00 | $9,000 | 1,800 | — | plan? |
| Nov 16, 2015 SForm 4 → | Nov 18, 4:13 pm EST | Michael StecherMedical Director | 1,800 | $14.00 | $25,200 | 0 | −100% | plan? amended |
| Nov 16, 2015 MForm 4 → | Nov 18, 4:13 pm EST | Michael StecherMedical Director | 1,800 | $5.00 | $9,000 | 1,800 | — | plan? amended |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2019 MForm 4 → | Mar 4, 4:13 pm EST | Sushma ShivaswamyChief Scientific Officer | 4,500 | — | — | 0 | — | |
| Jan 4, 2019 AForm 4 → | Mar 4, 4:51 pm EST | Sushma ShivaswamyChief Scientific Officer | 15,000 | — | — | 15,000 | — | late |
| Jan 4, 2019 AForm 4 → | Mar 4, 4:48 pm EST | Queena HanVP Finance & HR | 25,000 | — | — | 25,000 | — | late |
| Dec 19, 2018 MForm 4 → | Dec 20, 11:00 am EST | John SimardChief Executive Officer, Director, 10% Owner | 50,000 | — | — | 0 | — | |
| Jul 27, 2018 AForm 4 → | Oct 12, 3:00 pm EDT | John SimardChief Executive Officer, Director, 10% Owner | 15,000 | — | — | 15,000 | — | late |
| Jun 19, 2018 AForm 4 → | Jun 21, 3:17 pm EDT | Jan-Paul WaldinDirector | 12,500 | — | — | 12,500 | — | |
| Jun 19, 2018 AForm 4 → | Jun 21, 3:15 pm EDT | Donald H. MacAdamDirector | 12,500 | — | — | 12,500 | — | |
| Jun 19, 2018 AForm 4 → | Jun 21, 3:14 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 25,000 | — | — | 25,000 | — | |
| Jun 19, 2018 AForm 4 → | Jun 21, 3:13 pm EDT | John SimardChief Executive Officer, Director, 10% Owner | 200,000 | — | — | 200,000 | — | |
| May 8, 2018 AForm 4/A → | Jun 21, 4:48 pm EDT | Queena HanVP Finance & HR | 40,000 | — | — | 40,000 | — | |
| May 8, 2018 MForm 4 → | May 11, 11:39 am EDT | Queena HanVP Finance & HR | 40,000 | $4.16 | $166,400 | 40,000 | — | late |
| Mar 21, 2018 MForm 4 → | Mar 26, 3:39 pm EDT | Queena HanVP Finance & HR | 80,000 | — | — | 0 | — | late |
| Mar 20, 2018 AForm 4 → | Mar 22, 3:34 pm EDT | Donald H. MacAdamDirector | 25,000 | — | — | 25,000 | — | |
| Feb 27, 2018 AForm 4 → | Mar 1, 5:10 pm EST | Jan-Paul WaldinDirector | 25,000 | — | — | 25,000 | — | |
| Nov 20, 2017 AForm 4 → | Nov 22, 7:14 am EST | Sushma ShivaswamyChief Scientific Officer | 150,000 | — | — | 150,000 | — | |
| Jul 7, 2017 AForm 4 → | Jul 11, 12:20 pm EDT | Benjamin GuzmanSr.VP Corp. Strategy & Finance | 300,000 | — | — | 300,000 | — | |
| Jun 19, 2017 MForm 4 → | Jun 26, 3:47 pm EDT | Daniel VasellaDirector | 50,000 | $4.24 | $212,000 | 50,000 | — | late |
| Jun 19, 2017 MForm 4/A → | Jun 23, 2:59 pm EDT | Sushma ShivaswamyVP Research and Development | 50,000 | $4.24 | $212,000 | 50,000 | — | |
| Jun 19, 2017 MForm 4/A → | Jun 23, 2:57 pm EDT | Michael StecherMedical Director | 50,000 | $4.24 | $212,000 | 50,000 | — | |
| Jun 19, 2017 MForm 4/A → | Jun 23, 2:55 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 50,000 | $4.24 | $212,000 | 50,000 | — | |
| Jun 19, 2017 MForm 4/A → | Jun 23, 2:54 pm EDT | John SimardChief Executive Officer, Director, 10% Owner | 75,000 | $4.24 | $318,000 | 75,000 | — | |
| Jun 19, 2017 MForm 4/A → | Jun 23, 2:51 pm EDT | Queena HanVP Finance & HR | 30,000 | $4.24 | $127,200 | 50,000 | — | |
| Jun 19, 2017 MForm 4 → | Jun 23, 2:21 pm EDT | Fabrizio BonanniDirector | 50,000 | $4.24 | $212,000 | 50,000 | — | late |
| Jun 19, 2017 MForm 4 → | Jun 23, 2:18 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 50,000 | $4.24 | $212,000 | 50,000 | — | late amended |
| Jun 19, 2017 MForm 4 → | Jun 23, 2:17 pm EDT | John SimardChief Executive Officer, Director, 10% Owner | 75,000 | $4.24 | $318,000 | 75,000 | — | late |
| Jun 19, 2017 MForm 4 → | Jun 23, 2:15 pm EDT | Sushma ShivaswamyVP Research and Development | 50,000 | $4.24 | $212,000 | 50,000 | — | late |
| Jun 19, 2017 MForm 4 → | Jun 23, 2:14 pm EDT | Michael StecherMedical Director | 50,000 | $4.24 | $212,000 | 50,000 | — | late |
| Jun 19, 2017 MForm 4 → | Jun 23, 2:12 pm EDT | Queena HanVP Finance & HR | 30,000 | $4.24 | $127,200 | 50,000 | — | late |
| May 24, 2017 MForm 4 → | May 25, 5:12 pm EDT | John SimardChief Executive Officer, Director, 10% Owner | 240,000 | — | — | 0 | — | |
| Dec 1, 2016 ADForm 4 → | Dec 8, 11:13 am EST | Daniel VasellaDirector | 273,867 | — | — | 125,000 | — | late |
| Sep 14, 2016 MForm 4 → | Sep 16, 3:07 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 50,000 | $13.26 | $663,000 | 50,000 | — | |
| Sep 14, 2016 MForm 4 → | Sep 16, 3:05 pm EDT | Fabrizio BonanniDirector | 50,000 | $13.26 | $663,000 | 50,000 | — | |
| Sep 14, 2016 MForm 4 → | Sep 16, 2:58 pm EDT | Daniel VasellaDirector | 50,000 | $13.26 | $663,000 | 50,000 | — | |
| Sep 8, 2016 MForm 4 → | Nov 17, 4:01 pm EST | Queena HanVP Finance & HR | 19,573 | — | — | 0 | — | late |
| Sep 8, 2016 MForm 4 → | Sep 12, 3:45 pm EDT | Queena HanVP Finance & HR | 427 | — | — | 19,573 | — | |
| Jun 20, 2016 AForm 4 → | Aug 15, 12:31 pm EDT | Trey BensonVP of Commercial Development | 8,000 | — | — | 8,000 | — | late |
| May 16, 2016 AForm 4 → | May 19, 3:42 pm EDT | Dawn McColloughVP Clinical Operations | 50,000 | — | — | 50,000 | — | late |
| May 2, 2016 AForm 4 → | May 3, 2:58 pm EDT | James Scott WhitehurstChief Financial Officer | 300,000 | $12.99 | $3,897,000 | 300,000 | — | |
| Mar 31, 2016 MForm 4 → | May 2, 5:29 pm EDT | John SimardChief Executive Officer, Director, 10% Owner | 50,000 | $9.45 | $472,500 | 50,000 | — | late |
| Mar 17, 2016 OForm 4 → | Mar 22, 6:04 pm EDT | John SimardDirector, 10% Owner | 500,000 | $10.00 | $5,000,000 | 0 | — | late |
| Mar 17, 2016 OForm 4 → | Mar 22, 6:02 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 500,000 | $10.00 | $5,000,000 | 0 | — | late |
| Mar 1, 2016 MForm 4 → | May 2, 5:30 pm EDT | Daniel VasellaDirector | 125,000 | $7.79 | $973,750 | 125,000 | — | late |
| Mar 1, 2016 MForm 4 → | May 2, 5:29 pm EDT | W Thorpe McKenzieDirector, 10% Owner | 15,000 | $7.79 | $116,850 | 15,000 | — | late |
| Mar 1, 2016 MForm 4 → | May 2, 5:28 pm EDT | Fabrizio BonanniDirector | 33,333 | $7.79 | $259,664 | 33,333 | — | late |
| Dec 18, 2015 MForm 4 → | Dec 22, 7:23 pm EST | Queena HanVP Finance / HR | 30,000 | — | — | 20,000 | — | |
| Dec 16, 2015 MForm 4/A → | Dec 23, 8:38 am EST | Queena HanVP Finance / HR | 30,000 | — | — | 20,000 | — | |
| Dec 14, 2015 MForm 4 → | Aug 15, 2016, 2:31 pm EDT | Kalidip ChoudhuryVP of Business Development | 50,000 | $7.71 | $385,500 | 50,000 | — | late |
| Nov 16, 2015 MForm 4/A → | Nov 19, 11:00 am EST | Michael StecherMedical Director | 1,800 | — | — | 58,200 | — | |
| Nov 16, 2015 MForm 4 → | Nov 18, 4:13 pm EST | Michael StecherMedical Director | 1,800 | — | — | 58,200 | — | amended |
| Jun 8, 2015 AForm 4 → | Jun 10, 4:58 pm EDT | Kelly ThornburgSVP of Operations | 70,368 | — | — | 70,368 | — |